Understanding HPCA-Associated Dystonia (DYT2)
At a Glance
HPCA-associated dystonia is a very rare inherited movement disorder usually beginning in childhood with focal dystonia that may spread. DYT2 is an older clinical label; genetic testing helps confirm HPCA involvement, while symptoms and progression vary.
Learning that you or your child has HPCA-associated dystonia often means entering a world of very rare medical knowledge. Because this condition is so uncommon, even experienced neurologists may have never encountered a case in their practice. It is completely normal to feel uncertain when facing a diagnosis with limited research. This page explains what is currently understood about how the condition works, its history, and how it typically progresses.
The Connection to DYT2
For many years, doctors used the clinical label DYT2 to describe a specific pattern of movement disorder: a form of dystonia that begins in childhood, is inherited from both parents (autosomal recessive), and usually involves the body’s movements without affecting other parts of the brain [1].
As genetic testing has improved, researchers discovered that mutations in the HPCA gene are responsible for many cases that fit this historical DYT2 description [2]. Today, the medical community is moving toward naming these conditions based on the specific gene involved. If you see the term DYT2 in older medical records or research, it is often referring to a historical label. It is important to know that older records may not have had modern molecular confirmation, so a historical DYT2 label should not substitute for reviewing the actual genetic report [1][3].
Understanding the Rarity
HPCA-associated dystonia is considered exceptionally rare. To put this in perspective, a study of one specific cohort of 73 Italian children and young adults with similar movement disorders found that not a single one of them had a mutation in the HPCA gene [3]. Additionally, a literature review noted fewer than 20 documented cases globally [1]. While these numbers are snapshots in time and do not establish a definitive population prevalence, they highlight that the condition is rarely seen in standard clinical practice.
Because it is so rare, there is no “standard” experience, and reported case counts cannot predict your own course. Every individual’s journey provides new information, and research is still evolving to understand the full range of how this condition can appear [1][4].
The Role of Hippocalcin
The HPCA gene provides the instructions for making a protein called hippocalcin [5].
- Where it works: Hippocalcin is found at very high levels in the striatum, a part of the brain that acts like a command center for coordinating smooth, intentional movements [6].
- How it works: It serves as a neuronal calcium sensor. When calcium levels rise in a brain cell, hippocalcin changes shape and moves to the cell’s membrane to help manage electrical signals [7].
- What is thought to go wrong: Current models propose that in HPCA-associated dystonia, the protein cannot sense or respond to calcium correctly. This is thought to disrupt calcium-dependent signaling, leading to neuronal excitability—meaning the brain cells involved in movement may become overactive [8][6].
Disease Course and Progression
The way this condition progresses can vary widely, but researchers have identified a general pattern in the reported cases.
Age of Onset
Symptoms usually begin in childhood, though the reported range is broad—from infancy through early adulthood [1].
Movement Patterns
- Initial Symptoms: The condition often starts as focal dystonia, meaning it affects just one part of the body, such as a limb or the neck [3].
- Spread: Over time, the involuntary movements often spread to other areas. This is known as generalization, where the dystonia eventually affects most of the body [1].
- Movement Types: While slow, twisting movements (dystonia) are the primary feature, occasional reports show that some individuals also experience chorea (jerky, dance-like movements) or tremors [1][2].
Associated Features
While many historical cases were described as “isolated” (meaning only movement was affected), more recent reports show that some individuals may face additional challenges, though these are not guaranteed to happen. These occasional reported features include:
- Delays in reaching developmental milestones [1].
- Difficulty with executive function, which involves tasks like planning, focusing, and following multi-step directions [2].
- Speech difficulties (dysarthria) or, rarely, seizures [1][2].
Brain scans, such as an MRI, are typically normal, as the issue lies in how the cells communicate rather than in the physical structure of the brain [1]. Because common medications for dystonia often have a limited effect on this specific genetic form, your care team may explore various specialized approaches to manage symptoms as they arise [1][4].
Common questions in this guide
What is HPCA-associated dystonia, and what does DYT2 mean?
What are the usual symptoms of HPCA-associated dystonia?
When does HPCA-associated dystonia start, and does it get worse?
Is HPCA-associated dystonia inherited?
Can an MRI detect HPCA-associated dystonia?
How is HPCA-associated dystonia diagnosed?
What treatment options are available if standard dystonia medicines do not help?
Get notified when new evidence is published on Primary dystonia, DYT2 type.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
Childhood-Onset Choreo-Dystonia Due to a Recurrent Novel Homozygous Nonsense HPCA Variant: Case Series and Literature Review.
Magrinelli F, Bhatia KP, Beiraghi Toosi M, et al.
Movement disorders clinical practice 2023; (10(1)):101-108 doi:10.1002/mdc3.13529.
PMID: 36698997 - 2
Specific Cognitive Changes due to Hippocalcin Alterations? A Novel Familial Homozygous Hippocalcin Variant Associated with Inherited Dystonia and Altered Cognition.
Siegert S, Schmidt WM, Pletschko T, et al.
Neuropediatrics 2021; (52(5)):377-382 doi:10.1055/s-0040-1722686.
PMID: 33511595 - 3
DYT2 screening in early-onset isolated dystonia.
Carecchio M, Reale C, Invernizzi F, et al.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2017; (21(2)):269-271 doi:10.1016/j.ejpn.2016.10.001.
PMID: 27771228 - 4
Case Report of Pediatric HPCA-Associated Dystonia: Analysis of Ca2+ and K+ Channel Dynamics and Experience With Pallidal Deep Brain Stimulation.
Nou-Fontanet L, Ousingsawat J, Aziz M, et al.
Pediatric neurology 2025; (172()):46-52 doi:10.1016/j.pediatrneurol.2025.07.020.
PMID: 40884872 - 5
Mutations in HPCA cause autosomal-recessive primary isolated dystonia.
Charlesworth G, Angelova PR, Bartolomé-Robledo F, et al.
American journal of human genetics 2015; (96(4)):657-65.
PMID: 25799108 - 6
Biophysical and functional characterization of hippocalcin mutants responsible for human dystonia.
Helassa N, Antonyuk SV, Lian LY, et al.
Human molecular genetics 2017; (26(13)):2426-2435 doi:10.1093/hmg/ddx133.
PMID: 28398555 - 7
Mini-review: "Hippocalcin: Molecular mechanisms and therapeutic potential in neuronal function".
Park SY
Neuroscience letters 2025; (869()):138427 doi:10.1016/j.neulet.2025.138427.
PMID: 41115498 - 8
Perturbed Ca2+-dependent signaling of DYT2 hippocalcin mutant as mechanism of autosomal recessive dystonia.
Osypenko DS, Dovgan AV, Kononenko NI, et al.
Neurobiology of disease 2019; (132()):104529 doi:10.1016/j.nbd.2019.104529.
PMID: 31301343
This page is for informational purposes only and does not constitute medical advice about HPCA-associated dystonia or DYT2. A neurologist or movement-disorder specialist should interpret genetic results and discuss monitoring and symptom management.